Bullish
For adults with rare autoimmune anemia, China fast-tracks HUTCHMED drug
HUTCHMED (Nasdaq/AIM: HCM; HKEX: 13) announced that its New Drug Application (NDA) for sovleplenib to treat adult warm antibody autoimmune hemolytic a...